D-0642-2025 Class II

Recalled by Lannett Company Inc. — Seymour, IN

FDA drug recall D-0642-2025 was initiated by Lannett Company Inc. on Aug 19, 2025 and is designated Class II. Reason for recall: Presence of Foreign Tablet/Capsule: Two (2) bottles labeled as Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets, 10mg, 100ct, contained… Affected quantity: 4,848 bottles.

Recall details

Product Type
Drugs
Report Date
Sep 17, 2025
Initiation Date
Aug 19, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
4,848 bottles

Product description

Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets, 10mg, 100 Tablets per bottle, Rx only, Distributed by: Lannett Company, Inc., Philadelphia, PA 19136, NDC 0527-0762-37.

Reason for recall

Presence of Foreign Tablet/Capsule: Two (2) bottles labeled as Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets, 10mg, 100ct, contained one (1) tablet of Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets, 5 mg.

Distribution pattern

OH

Code information

Lot#: 25283185A. Expiry: 02/28/2027

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0642-2025
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0642-2025. Report a data issue: hello@regdatalab.com.